SCHEMBL6809186

SCHEMBL6809186

CC(Cc1ccc(C(C)C(=O)O)cc1)NC[C@H](O[Si](C)(C)C(C)(C)C)c1ccc(O)c(CO)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 14/20 0.44
NFKB1 P19838 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
HIF1A Q16665 1/20 0.40
ADRB1 P08588 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
PMP22 Q01453 1/20 0.39
CASP3 P42574 1/20 0.38
CASP6 P55212 1/20 0.38
LMNA P02545 1/20 0.38
ALB P02768 1/20 0.38
ESR1 P03372 1/20 0.38
ALOX5 P09917 1/20 0.38
RARB P10826 1/20 0.38
CYP2C9 P11712 1/20 0.38
ADRB3 P13945 1/20 0.38
PTGS1 P23219 1/20 0.38
HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4255088 1.00 ADRB2 (0.44) ADRB2NFKB1CYP1A2CYP2D6TSHR
SCHEMBL4255087 1.00 ADRB2 (0.44) ADRB2NFKB1CYP1A2CYP2D6TSHR
SCHEMBL4257700 0.91 ADRB2 (0.49) ADRB2NFKB1CYP1A2CYP2D6TSHR
SCHEMBL4263998 0.91 ADRB2 (0.49) ADRB2NFKB1CYP1A2CYP2D6TSHR
SCHEMBL4253565 0.91 ADRB2 (0.46) ADRB2NFKB1CYP1A2CYP2D6TSHR
SCHEMBL14422856 0.91 ADRB2 (0.46) ADRB2NFKB1CYP1A2CYP2D6TSHR
SCHEMBL4253746 0.87 ADRB2 (0.52) ADRB2ADRB1
SCHEMBL4256408 0.86 ADRB3 (0.37) ADRB2ADRB1CASP3CASP6ADRB3
SCHEMBL6919440 0.86 ADRB3 (0.37) ADRB2ADRB1CASP3CASP6ADRB3
SCHEMBL4256407 0.86 ADRB3 (0.37) ADRB2ADRB1CASP3CASP6ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040229904-A1 Compounds useful for the treatment of diseases PFIZER INC 2004-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040229904-A1 Compounds useful for the treatment of diseases LTC4S, CYP11B1, CYP11B2 ADRB2 901/4885NFKB1 320/4885CYP1A2 40/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.